Philadelphia University + Thomas Jefferson University
Institute of Emerging Health Professions
Lambert Center for the Study of Medicinal Cannabis & Hemp

News & Events

Lambert Center Media Coverage

Up-to-date Steering Committee Article Citations

Loflin M, Babson, K,  Browne, K,  Bonn-Miller, M. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. American Journal of Drug and Alcohol Abuse. 2017; http://dx.doi.org/10.1080/00952990.2017.1376677

DeKovel CGF, Syrbe S,  Brilstra EH….Marsh E…et al. Neurodevelopmental disorders caused by de novo variants in KCNB1 genotypes and phenotypes. JAMA Neurology. 2017; 74:1228-1236.

Masnada S,  Hedrich UBS,  Gardella E….Marsh E…et al. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies. Brain. 2017; 140; 2337-2354.

Huestis MA, Brandt SD, Rana S, et al. Impact of novel psychoactive substances on clinical and forensic toxicology and global public health. Clinical Chemistry. 2017; 63: 1564-1569.

Foxwell AM, Moyer ME,  Casarett DJ, et al. Palliative care office hours for patients with hematologic malignancies: An Innovative model for symptom management and education. Journal of Palliative Medicine. 2017; 20: 1148-1151.

Banducci AN,  Connolly KM,  Vujanovic AA… Bonn-Miller MO. The impact of changes in distress tolerance on PTSD symptom severity post-treatment among veterans in residential trauma treatment. Journal of Anxiety Disorders. 2017; 47: 99-105.


News & Events Archive

May 2, 2017

Ex-NFL Players Attend Lambert Center Meeting to Discuss Medical Marijuana

During a three-day summit at the Union League of Philadelphia, attendees of various backgrounds from around the world gathered to discuss medical marijuana.  Three former NFL players and one former NHL player joined on the second day of the summit.  Players in attendance were Todd Herremans, former offensive lineman for the Eagles; Lance Johnston, former defensive end for the Oakland Raiders and Minnesota Vikings; Marques Colston, former wide receiver for New Orleans Saints; and Riley Cote, hemp advocate and once an enforcer for the Flyers.

Watch Dr. Charles Pollack's interview with Philly.com here.


March 30, 2017

Dr. Charles Pollack Discusses Cannabis as Medicine with GreenSea Distribution

Read full interview here


February 22, 2017

Lambert Center Entrepreneurship & Social Impact Initiative Member, Lindy Snider, Invests in Medical Marijuana

Lindy Snider, whose late father, Ed Snider, benefited from medical cannabis when he had metastatic bladder cancer, is dully supporting the shift in Pennsylvania's medical marijuana industry.  During the last few months of her father's life, his appetite dwindled but cannabis soon restored that.  

Along with being a member of the Entrepreneurship and Social Impact Initiative for The Lambert Center, Snider has a startup called Lindi Skin (skin care products for cancer patients) and serves on the board for KindFinancial (cannabis industry banking).  

Snider's goal is to build a 125,000-square-foot cannabis growing facility near the Bucks County line that would employ up to 50 people.  If the Pennsylvania Department of Health accepts her application, which is due by March 20th, marijuana production would begin in 2018.  Snider has been deemed a front-runner in a pool of about 800 applicants. 

See the full article here.


December 22, 2016

Jefferson Receives $1.5 Million from Six Organizations to Support Cannabis Research & Education

The Lambert Center for the Study of Medicinal Cannabis and Hemp, funded entirely through philanthropy, has received a combined $1.5 million from six Pennsylvania organizations.

“We are recognizing these organizations as our ‘Founding Supporters’, because these gifts are enabling us to build the research infrastructure of The Lambert Center,” said Charles V. Pollack Jr., MA, MD, Director of Jefferson’s Institute of Emerging Health Professions. “We are very grateful for this cascade of generosity. It’s a strong vote of confidence in this unique academic endeavor.” 

The initial six Founding Supporters are: The Tuttleman Family Foundation, PharmaCannis, PA Options for Wellness, Commonwealth Alternative Medicinal Options, Keystone Wellness Research Fund, LLC, and Oha Wellness.

This support will drive educational initiatives and unbiased medical cannabis research.

Read the full press release here.


Barry Lambert

December 7, 2016

IEHP receives $3 Million from Australian Philanthropist, Barry Lambert

The Center of Cannabis Research and Education (CMCER) has been renamed to The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University.

Barry Lambert, 70, is renowned in the Australian banking industry for founding Count Financial, Australia’s largest network of accounting-based advisory firms. It was the love only a grandparent can feel that inspired the Lamberts’ philanthropy. As an infant, Barry and Joy’s granddaughter, Katelyn, was diagnosed with Dravet’s syndrome, a rare genetic abnormality that affects the brain's electric signaling system and causes severe and repetitive seizures. Medical cannabis has been shown to be one of the few therapies that mitigates the seizures caused by the condition, and cannabis derived from hemp indeed gave Katelyn substantial relief. The Lamberts’ gift reflects a belief that more study into medicinal cannabis will offer greater hope for others with this and other diverse conditions. Read more from the press release here.

For more media coverage:

Philadelphia Magazine
Philadelphia Business Journal
Philly Voice
Philadelphia Inquirer


October 28-30, 2016

Carolina Cannabinoid Collaborative Conference

Temple’s Lewis Katz School of Medicine and its Center for Substance Abuse Research and The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University (LCSMCH) will be co-presenting the 2016 Carolina Cannabinoid Collaborative Conference on October 28th-30th. Over 100 of the country’s leading cannabinoid researchers will gather here in Philadelphia to address recent developments and discoveries. The Conference will feature Keynote speakers, Donald Abrams, MD, Chief of Hematology-Oncology at Zuckerberg San Francisco General Hospital, a member of LCSMCH’s international Academic Steering Committee, and Yasmin Hurd, PhD, Professor of Psychiatry, Neuroscience and Pharmacology and Systems Therapeutics, and Director of the Center for Addictive Disorders at the Icahn School of Medicine at Mount Sinai.  

Read the press release here.